RVX Chart by TradingView

Business Description

Resverlogix is a biotechnology company focused on the two largest drug markets – cancer and cholesterol. Its unique technology is focused on increasing HDL’s (good cholesterol) as opposed to the more common focus of lowering LDL’s (bad cholesterol).

Website http://www.resverlogix.com/


Resverlogix Announces Voting Results from the 2022 Meeting of Shareholders Jun. 22, 2022
Resverlogix Announces New Research Findings Highlighting the Safety of BD2-selective BET Inhibitors Jun. 8, 2022
Resverlogix Announces Type C Meeting with FDA for CORAL, a Phase 3 High-risk COVID-19 Outpatient Study May. 9, 2022
Resverlogix Announces One-Year Extension of Debenture Apr. 19, 2022
Apabetalone’s Positive Impact on Pulmonary Arterial Hypertension Published in the American Journal of Respiratory and Critical Care Medicine Mar. 17, 2022

Investors are also interested in these companies: